Newsroom
-
Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Business WireLearn More -
Mammoth Biosciences is getting closer to finding out if its big bet on tiny CRISPR enzymes will pay off
Endpoints NewsLearn More -
Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress
Business WireLearn More -
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
Business WireLearn More -
Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025
Business WireLearn More -
AAV Delivered NanoCas CRISPR System Edits Muscle in Non-Human Primates
Genetic Engineering & Biotechnology NewsLearn More -
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
Business WireLearn More -